
Myths vs. Facts about Diet in Multiple Myeloma
In this informative show, Jenny Ahlstrom interviews Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center about her pioneering NUTRIVENTION studies examining how diet impacts multiple myeloma progression and treatment outcomes.
Dr. Shah shared results from her completed NUTRIVENTION study, now published in Cancer Discovery, which showed that a high-fiber plant-based diet significantly improved key cancer risk markers in MGUS and smoldering myeloma patients. Over 12 weeks, participants' plant-based food intake increased from 20% to 90% of calories, leading to reduced inflammation (C-reactive protein levels dropped), improved microbiome diversity, decreased insulin levels, and better quality of life. Two patients with previously progressing disease showed trajectory slowdown.
The interview also covered Dr. Shah's three active studies: NUTRIVENTION 2 (closing soon, 100 patients nationwide studying microbiome changes with supplements vs. diet), NUTRIVENTION 3 (150 patients at MSK or Emory comparing diet alone vs. diet with omega-3/curcumin), and NUTRIVENTION 5 (200+ newly diagnosed patients examining whether diet during initial treatment improves outcomes and actively recruiting).
In the show, Dr. Shah compared a whole foods plant-based diet with a ketogeneic diet and discussed the need for more fiber in the typical American diet.
The discussion also addressed five common nutrition myths:
- Myth 1: All carbohydrates are bad and should be avoided for cancer patients
- Myth 2: Diet can't meaningfully change the gut microbiome during cancer
- Myth 3: Plant proteins are incomplete and this is why we need a lot of animal proteins
- Myth 4: You should only eat organic fruits and vegetables
- Myth 5: Soy increases the risk of breast cancer
Additional commonly asked patient questions were also answered during the show. If you are interested in participating in these groundbreaking studies, please contact shahNUTRIVENTION@mskcc.org.

Jenny Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Urvi Shah, MD
Dr. Urvi Shah is a faculty on the myeloma service, division of hematologic malignancies at Memorial Sloan Kettering Cancer Center. Her research focuses on studying the role of diet, microbiome, and other lifestyle-related risk factors in plasma cell disorders as well as identifying interventions to improve outcomes for these patients. She also studies immune therapies (including CAR T cell therapies) for myeloma. Being a lymphoma survivor herself she is passionate about helping patients make wise nutritional and lifestyle choices as they face a plasma cell disorder diagnosis as well as raising awareness about healthy choices to prevent cancer.
Myths vs. Facts about Diet in Multiple Myeloma
